TEVA Teva Pharmaceutical Industries Limited
$39.19
Teva Pharmaceutical Industries Limited (TEVA) is confirmed to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $0.71 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +16.4% since its last earnings release on July 29, 2026.
Teva Pharmaceutical Industries Limited Missed Consensus Estimates, Guides In-line
Wednesday, July 29, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 7:00 AM ET
Earnings Whisper
-
vs $0.71
Rev est $4.3B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$36.81
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd develops, produces and markets generic, branded & OTC medicines. Some of its products are Copaxone, Azilect & Provigil.
Sector
Healthcare
Industry
Drugs - Generic
Held By 15 ETFs, by dollar flow
- PPH VanEck Pharmaceutical ETF
- PPH VanEck Pharmaceutical ETF
- IXUS iShares Core MSCI Total International Stock ETF
- IXUS iShares Core MSCI Total International Stock ETF
- ACWX iShares MSCI ACWI ex U.S. ETF
- ACWX iShares MSCI ACWI ex U.S. ETF
- IEFA iShares Core MSCI EAFE ETF
- IEFA iShares Core MSCI EAFE ETF
- IDEV iShares Core MSCI International Developed Markets ETF
- IDEV iShares Core MSCI International Developed Markets ETF
- EFA iShares MSCI EAFE ETF
- EFA iShares MSCI EAFE ETF
- EFG iShares MSCI EAFE Growth ETF
- EFG iShares MSCI EAFE Growth ETF
- EIS iShares MSCI Israel ETF
Charts powered in part by Lightweight Charts™ by TradingView.